Inhibition of AMP-Activated Protein Kinase Accentuates Lipopolysaccharide-Induced Lung Endothelial Barrier Dysfunction and Lung Injury in Vivo

The aim of this study was to determine the role of AMP-activated protein kinase (AMPK) in lipopolysaccharide (LPS)-induced lung endothelial barrier dysfunction and lung injury in vivo. Both cultured human pulmonary artery endothelial cells (HPAECs) and experimental animals [AMPK subunit α–deficient...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Xing, Junjie, Wang, Qilong, Coughlan, Kathleen, Viollet, Benoit, Moriasi, Cate, Zou, Ming-Hui
Format: Artigo
Langue:Inglês
Publié: American Society for Investigative Pathology 2013
Sujets:
Regular Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3589075/
https://ncbi.nlm.nih.gov/pubmed/23306156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajpath.2012.11.022
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires